Back to News
Market Impact: 0.45

Wells Fargo initiates Boeing stock coverage with overweight rating By Investing.com - ca.investing.com

BACWFCBASMCIAPP
Analyst InsightsAnalyst EstimatesCompany FundamentalsCorporate Guidance & OutlookCorporate EarningsInfrastructure & DefenseRegulation & LegislationTransportation & Logistics
Wells Fargo initiates Boeing stock coverage with overweight rating By Investing.com - ca.investing.com

Wells Fargo initiated coverage on Boeing with an Overweight rating and a $250 price target based on a 20x 2028 free cash flow multiple, expecting a material recovery from LTM negative FCF of -$1.88B. Boeing secured a $326M U.S. Department of War CH-47F contract and a 103-aircraft order from Korean Air worth $36.2B (2026-2039); Tigress raised its price target to $290 (Buy). Management reports the commercial airplane division posted losses of $632M in 2025 (vs $2.1B in 2024) and expects flat-to-positive margins by 2026, while Wells Fargo expects 777X headwinds to abate as production approaches 3-4 aircraft/month toward decade-end.

Analysis

Higher OEM production expectations create a bifurcated payoff: the market is pricing a path to outsized free cash flow several years out, but the conduit to realize that cash is a measurable supply-chain and working-capital unwind. If deliveries scale on schedule, inventory liquidation and receivable conversion can materially accelerate FCF conversion without a simultaneous margin expansion — that plumbing effect can add 20–40% of near-term implied equity value before product-margin improvements show up. Conversely, the hidden friction is supplier capacity and re-pricing. Many Tier-1 composite, landing-gear and interior suppliers are near multi-year utilization inflection points; incremental rate increases are likelier to hit supplier lead-times or force onerous price reopeners than to flow cleanly to OEM gross margins. That raises the odds of either delayed deliveries (pushing cash out) or margin erosion through renegotiated supplier costs. Macro and regulatory regimes are second-order multipliers. A modest move higher in the real discount rate (200–300bp) trims 3–4-year-forward FCF present value by low-double-digit percent, while any reversion to more adversarial certification oversight amplifies execution risk and extends the time-to-cash. The fastest observable confirmation of the bullish path will be stable monthly delivery cadence and progressive working-capital drawdown reported quarter-to-quarter. For positioning, asymmetry is key: buy optionality on a clean execution path while capping downside to near-term uncertainty. The highest-probability upside comes from demonstrating repeatable production and visible aftermarket margin leverage; the most likely ways the story breaks are supplier bottlenecks, a regulatory snag, or macro demand softness for widebodies that defers cash recovery.